blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2450041

EP2450041 - Improved testosterone gel for use in the treatment of hypogonadism [Right-click to bookmark this link]
Former [2012/19]Improved testosterone gel and method of use
[2018/14]
StatusNo opposition filed within time limit
Status updated on  02.08.2019
Database last updated on 14.11.2024
FormerThe patent has been granted
Status updated on  24.08.2018
FormerGrant of patent is intended
Status updated on  05.04.2018
FormerExamination is in progress
Status updated on  14.07.2017
Most recent event   Tooltip02.08.2019No opposition filed within time limitpublished on 04.09.2019  [2019/36]
Applicant(s)For all designated states
Unimed Pharmaceuticals, LLC
c/o Abbott Laboratories
100 Abbott Park Road, Department 0377
Building AP6A-1
Abbott Park, IL 60064-6008 / US
For all designated states
Besins Healthcare Luxembourg SARL
2-8 rue Julien Vesque
2668 Luxembourg / LU
[2018/39]
Former [2015/23]For all designated states
Unimed Pharmaceuticals, LLC
c/o Abbott Laboratories
100 Abbott Park Road, Department 0377
Building AP6A-1
Abbott Park, IL 60064-6008 / US
For all designated states
Besins Healthcare Luxembourg SARL
2-8 rue Julien Vesque
2668 Luxembourg / LU
Former [2012/29]For all designated states
Unimed Pharmaceuticals, LLC
C/O ABBOTT LABORATORIES
100 ABBOTT PARK ROAD, DEPARTMENT 0377
BUILDING AP6A-1
ABBOTT PARK, ILLINOIS 60064-6008 / US
For all designated states
Besins Healthcare Luxembourg SARL
67 boulevard Grande-Duchesse Charlotte
1331 Luxembourg / LU
Former [2012/19]For all designated states
Unimed Pharmaceuticals, LLC
901 Sawyer Road
Marietta, GA 30062 / US
For all designated states
Besins Healthcare Luxembourg SARL
67 boulevard Grande-Duchesse Charlotte
1331 Luxembourg / LU
Inventor(s)01 / Malladi, Ramana
901 Sawyer Road
GA 30062 Marietta / US
02 / Miller, Jodi
901 Sawyer Road
GA 30062 Marietta / US
 [2012/19]
Representative(s)Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
[2018/39]
Former [2014/07]Brown, David Leslie, et al
Haseltine Lake LLP
Redcliff Quay
120 Redcliff Street
Bristol BS1 6HU / GB
Former [2012/19]Cabinet Plasseraud
52, rue de la Victoire
75440 Paris Cedex 09 / FR
Application number, filing date11181638.512.10.2006
[2012/19]
Priority number, dateUS20050725276P12.10.2005         Original published format: US 725276 P
[2012/19]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2450041
Date:09.05.2012
Language:EN
[2012/19]
Type: A3 Search report 
No.:EP2450041
Date:01.08.2012
Language:EN
[2012/31]
Type: B1 Patent specification 
No.:EP2450041
Date:26.09.2018
Language:EN
[2018/39]
Search report(s)(Supplementary) European search report - dispatched on:EP28.06.2012
ClassificationIPC:A61K9/06, A61P5/26, A61K31/568, A61K47/14, A61K47/32, A61K47/10
[2018/14]
CPC:
A61K9/0014 (EP,NO,US); A61K31/56 (KR); A61K31/568 (EP,NO,US);
A61K47/10 (EP,US); A61K47/14 (EP,US); A61K47/32 (EP,US);
A61K9/06 (EP,KR,US); A61P5/26 (NO,US) (-)
Former IPC [2012/31]A61K31/568, A61K9/06, A61K47/10, A61K47/14, A61K47/32, A61P15/00, A61K9/70
Former IPC [2012/19]A61K31/568, A61K9/06, A61K47/10, A61K47/14, A61K47/32, A61P15/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2018/39]
Former [2012/19]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Verbessertes Testosterongel zur Verwendung in der Behandlung von Hypogonadismus[2018/14]
English:Improved testosterone gel for use in the treatment of hypogonadism[2018/14]
French:Gel améliore à base de testostérone pour utilisation dans le traitment de l'hypogonadisme[2018/17]
Former [2012/19]Verbessertes Testosterongel und Anwendungsverfahren dafür
Former [2012/19]Improved testosterone gel and method of use
Former [2012/19]Gel améliore à base de testostérone et procédé d'utilisation
Examination procedure01.02.2013Examination requested  [2013/11]
21.03.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
21.05.2013Amendment by applicant (claims and/or description)
14.07.2017Despatch of a communication from the examining division (Time limit: M04)
15.11.2017Reply to a communication from the examining division
05.04.2018Communication of intention to grant the patent
14.08.2018Fee for grant paid
14.08.2018Fee for publishing/printing paid
14.08.2018Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP06836341.5  / EP1937276
Divisional application(s)EP18195634.3  / EP3456329
EP24175665.9  / EP4397367
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060836341) is  09.09.2009
Opposition(s)27.06.2019No opposition filed within time limit [2019/36]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
21.05.2013Request for further processing filed
21.05.2013Full payment received (date of receipt of payment)
Request granted
05.06.2013Decision despatched
Fees paidRenewal fee
16.09.2011Renewal fee patent year 03
16.09.2011Renewal fee patent year 04
16.09.2011Renewal fee patent year 05
16.09.2011Renewal fee patent year 06
17.08.2012Renewal fee patent year 07
14.08.2013Renewal fee patent year 08
31.10.2014Renewal fee patent year 09
29.10.2015Renewal fee patent year 10
10.10.2016Renewal fee patent year 11
12.10.2017Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0217926  (UNIMED PHARMACEUTICALS INC [US], et al);
 [XI]WO03002123  (SOLVAY PHARMACEUTICALS INC [US]);
 [I]US2004072810  (MASINI-ETEVE VALERIE [FR], et al);
 [X]WO2004037173  (UNIMED PHARMACEUTICALS INC [US]);
 [X]US2005020552  (ASCHKENASY CHAIM [IL], et al);
 [X]US2005113353  (DUDLEY ROBERT E [US], et al);
 [X]US2005118242  (DUDLEY ROBERT E [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.